Testosterone concentration in young patients with diabetes - Wikidata - wikimedia - TriplyDB

Testosterone concentration in young patients with diabetes

Testosterone concentration in young patients with diabetes

http://www.wikidata.org/entity/Q36906249

about

Metabolic effects of testosterone replacement therapy on hypogonadal men with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials Testosterone concentrations in diabetic and nondiabetic obese men.The role of testosterone in the etiology and treatment of obesity, the metabolic syndrome, and diabetes mellitus type 2.Insulin resistance is an independent correlate of high serum levels of advanced glycation end products (AGEs) and low testosterone in non-diabetic men.Diet-induced obesity and low testosterone increase neuroinflammation and impair neural function Low testosterone concentration and atherosclerotic disease markers in male patients with type 2 diabetes.Low estradiol concentrations in men with subnormal testosterone concentrations and type 2 diabetes Update: Hypogonadotropic hypogonadism in type 2 diabetes and obesity Exercise training improves the defective centrally mediated erectile responses in rats with type I diabetes Androgen Deficiency and Erectile Dysfunction in Patients with Type 2 Diabetes.Testosterone concentration and insulin sensitivity in young men with type 1 and type 2 diabetes.Hormonal determinants of the severity of andropausal and depressive symptoms in middle-aged and elderly men with prediabetes Testosterone concentrations in young pubertal and post-pubertal obese males.Hypogonadotropic hypogonadism in men with type 2 diabetes.A study to evaluate the prevalence of hypogonadism in Indian males with Type-2 diabetes mellitus.Hypogonadism in men with erectile dysfunction may be related to a host of chronic illnesses.Sex steroids and glucose metabolism.Prevalence of low testosterone levels in men with type 2 diabetes mellitus: a cross-sectional study.The role of testosterone in type 2 diabetes and metabolic syndrome in men.Hypogonadism, erectile dysfunction, and type 2 diabetes mellitus: what the clinician needs to know.The role of obesity and type 2 diabetes mellitus in the development of male obesity-associated secondary hypogonadism.Obesity and sex interact in the regulation of Alzheimer's disease.Ameliorative effect of omega-3 on spermatogenesis, testicular antioxidant status and preimplantation embryo development in streptozotocin-induced diabetes in rats.RAS and sex differences in diabetic nephropathy.Testicular function during adolescence in boys with type 1 diabetes mellitus (T1D): absence of hypogonadism and differences in endocrine profile at the beginning and end of puberty.Correlates and prevalence of hypogonadism in patients with early- and late-onset type 2 diabetes.Effects of long-term testosterone replacement therapy, with a temporary intermission, on glycemic control of nine hypogonadal men with type 1 diabetes mellitus - a series of case reports.The connection between type 2 diabetes and erectile dysfunction in Taiwanese aboriginal males.Assessment of Hypogonadism in Men With Type 2 Diabetes: A Cross-Sectional Study From Saudi Arabia.Effect of testosterone on hepcidin, ferroportin, ferritin and iron binding capacity in patients with hypogonadotropic hypogonadism and type 2 diabetes.Association of metabolic syndrome, atherosclerosis risk factors, sex hormones in ED in aboriginal Taiwanese.Obesity and age as dominant correlates of low testosterone in men irrespective of diabetes status.Type 2 diabetes mellitus and testosterone: a meta-analysis study.Study on alcohol dependence and factors related to erectile dysfunction among aborigines in Taiwan.Total and free testosterone concentrations are strongly influenced by age and central obesity in men with type 1 and type 2 diabetes but correlate weakly with symptoms of androgen deficiency and diabetes-related quality of life.Androgen deficiency in male rats with prolonged neonatal streptozotocin diabetes.Testosterone increases GLUT4-dependent glucose uptake in cardiomyocytes.

P2860

Q26822761-8D2B47FF-0522-45D4-9F30-118AAF88CF5D Q33873019-17CE5761-864B-4040-B030-FB36FF8B68E2 Q34097510-5EB0938C-30E4-4897-85D0-4C089A9BF246 Q34185801-A7F71C29-E4C2-4710-90DF-3C218527740D Q34309465-3E09533B-4A03-4729-BD10-9ACA7100C7CD Q34628361-00A36684-A62B-4A9C-AB47-0662B2F0DCFB Q35123346-19FFE18E-8E63-4DB2-A4AE-B0E3DA40B501 Q35198511-409AAC7D-2D54-40AD-8676-312945D6D374 Q35476177-C61CECAF-A151-4E2B-81F4-AB732C55AD17 Q35871552-AA3ADEAB-D1A5-4C97-9D3B-435561BADFB9 Q35876203-91A2CE73-6456-45A2-93AD-0AE294A3E685 Q35994260-AD9F6725-AC0B-4AC2-8BB0-2F14D7980AA2 Q36472816-AF984713-4CB0-4AB2-BE2C-1DD1EB97A75C Q37505853-EE6CA8EE-8E73-4B7F-8F16-F74E3B2145C1 Q37588872-BB728926-1F99-481A-9EB8-48C14BAFDC3E Q37607090-9FE07849-E8B8-4A84-897F-AE50476EDC0D Q37639198-AD817646-5AD8-4F1E-B4B1-7B7D1D521DAD Q37642529-11860CD2-4C66-4F81-A9D0-1CB6CE6A801E Q37686143-9A0A1680-194E-4499-9295-5A1E50934B11 Q37810422-0EE3C866-FD03-47E8-B8FB-FCAD42215015 Q38057355-E2D2AA55-9C1B-4E14-812E-5D0E04EADE11 Q38680759-D5BEE6A8-360B-4C66-B07A-AEC8A854DE13 Q38721625-38809161-421B-4A48-AE1B-5985B6E11BDF Q38768074-91A047EB-27C0-429C-A9C3-4A841C17EA68 Q40143282-C7A4962C-002F-4528-AF6D-343925287074 Q40466391-2591426A-1B19-412B-B37F-01A7B656B609 Q40834816-A174F197-65D2-4A3A-866D-42319CB4F8AA Q42203776-1551BC0B-FED9-41ED-A72D-7B1245BE9222 Q42252900-8D6EB3A0-D78C-48C0-98FD-7DC83F8A3D0F Q42494574-80E798BB-5D4E-4589-983B-336C19B34B3E Q45032186-9C26E5DB-75C9-4642-8A23-710279EEED69 Q45173012-F6C197A5-F553-441C-86D1-8350F257F86A Q45921938-0B311396-9401-4E1C-B607-CD484F0E26DC Q48247445-0911FF53-B474-4C90-9376-C7271886FA3E Q48607948-EFC93E4E-DA51-47DC-85E0-130953AA0626 Q48925785-77ACC74F-98A0-4AEA-9CC7-892ABA292254 Q50916859-E97341E9-A41F-400E-B21B-E98AB3271834

P2860

Testosterone concentration in young patients with diabetes

http://www.wikidata.org/entity/Q36906249

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Testosterone concentration in young patients with diabetes

@en

type

label

Testosterone concentration in young patients with diabetes

@en

prefLabel

Testosterone concentration in young patients with diabetes

@en

P1433

Q36906249-C6CBE759-8A92-4AC1-8222-82180EF74A8A

P1476

Q36906249-EB2DF9A7-5B52-4B40-9F3E-688A814D3112

P2093

Q36906249-15879B36-3A51-4C22-BF12-9D3E2A65CD2C

Q36906249-1708BB47-E60B-4865-9A85-96DBBCA11932

Q36906249-2D58CEFD-E839-481F-91C5-86E30451F3BF

Q36906249-A1B253B3-0B96-4AAF-A0F1-0DACBDC665FB

Q36906249-D89FC3BA-87C3-4A60-B6FE-765FC1686480

P2860

Q36906249-0AC7CCA9-8AC2-45F0-8EBD-6B52077B2435

Q36906249-0E75697E-6B82-4B6A-B326-414F3B016A83

Q36906249-1232A221-E178-47CC-9937-689153D64FFE

Q36906249-33AFF980-EA83-4CC7-84FF-F4EA79749F2F

Q36906249-476BA21F-6C77-4BC7-83FA-8A938D83601B

Q36906249-63A4D5EB-DAE7-4450-AFCC-B21A0133EDE0

Q36906249-6E348470-034F-46B5-AD37-28DA5E7E323B

Q36906249-8448886E-BA73-4FC3-ACEA-9DA69A74E969

Q36906249-9CE879CA-7786-4F9E-BD02-6F594D086182

Q36906249-A1653899-C840-4CD9-9102-528974A361EE

P304

Q36906249-B501861F-74F8-40B8-9AE4-4CB496D28800

P31

Q36906249-28A3E344-1969-4FA4-91E9-F2B39022D2F3

P356

Q36906249-74938252-440B-4618-99A4-D47981716D80

P407

Q36906249-05E374E2-42F8-4481-BDB4-9264DDB3680F

P433

Q36906249-113936A3-51F1-49A0-8BDB-6FBD6D4C9F28

P478

Q36906249-8BBBE87F-8999-4617-B2A4-3553FB9279D6

P577

Q36906249-E33232E4-F5BC-4F82-9A58-901947B329FD

P5875

Q36906249-E503E9C0-57F0-497B-8A45-298F8F0B7FB2

P698

Q36906249-A56FCE80-BF4E-4F00-82D5-6123AD44EB15

P932

Q36906249-DB1748FE-B9CB-4209-81B7-422A8DFD6F4A

P356

P1433

P1476

Testosterone concentration in young patients with diabetes

@en

P2093

Ajay Chaudhuri

http://www.w3.org/2001/XMLSchema#string

Anil Chandel

http://www.w3.org/2001/XMLSchema#string

Paresh Dandona

http://www.w3.org/2001/XMLSchema#string

Sandeep Dhindsa

http://www.w3.org/2001/XMLSchema#string

Shehzad Topiwala

http://www.w3.org/2001/XMLSchema#string

P2860

Prevalence of hypogonadism in males aged at least 45 years: the HIM study.

Low serum testosterone and mortality in older men.

Hypogonadotrophic hypogonadism in type 2 diabetes, obesity and the metabolic syndrome.

Evaluation of assays available to measure free testosterone.

Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity.

Diagnosis of hypogonadism in the aging male.

Association between serum testosterone concentration and carotid atherosclerosis in men with type 2 diabetes.

Dose-dependent effects of testosterone on regional adipose tissue distribution in healthy young men.

Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes.

Serum androgen levels in black, Hispanic, and white men.

P304

2013-2017

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DC08-0851

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P577

2008-07-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51423964

http://www.w3.org/2001/XMLSchema#string

P698

18650372

http://www.w3.org/2001/XMLSchema#string

P932

2551646

http://www.w3.org/2001/XMLSchema#string